Advertisement

Topics

November’s top stories

19:00 EST 6 Dec 2018 | Pharmaceutical Technology

Sobi to buy US rights to AstraZeneca’s Synagis drug for $1.5bn Swedish biopharmaceutical firm Swedish Orphan Biovitrum (Sobi) signed agreements...
Read More...

The post November’s top stories appeared first on Pharmaceutical Technology.

Original Article: November’s top stories

NEXT ARTICLE

More From BioPortfolio on "November’s top stories"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...